Skip to main content
. Author manuscript; available in PMC: 2014 Jun 1.
Published in final edited form as: Prostate. 2013 Jan 17;73(9):905–912. doi: 10.1002/pros.22636

TABLE IV.

Multivariate Analysis of the Association of ERG Protein Composition Score With Clinical Outcomes as Assessed by Both Anti-ERG Antibodies

Clinical outcome EPR3864 ERG composite score (n) P-value 9FY ERG composite score (n) P-value
Biochemical relapse
    No 106 (48) 0.016 106 (44) 0.0093
    Yes 131 (29) 139 (28)
Local recurrence
    No 114 (74) 0.037 110 (69) 0.0046
    Yes 165 (3) 197 (3)
Distant metastases
    No 101 (48) 0.049 107 (44) 0.057
    Yes 124 (29) 119 (28)
PCSM
    No 108 (50) 0.0015 105 (56) 0.0002
    Yes 139 (17) 150 (16)

ERG, ETS-related gene; PCSM, prostate cancer-specific mortality.